GGrantIndex
Sort

30,917 grants matching tumor microenvironment

MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer

$395,738
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA

MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer

$395,738
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA

MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer

$395,738
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA

MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer

$395,738
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA

Trafficking of eRNAs in K-Ras Mutant Colon Cancer

$395,732
Robert J Coffey · Vanderbilt University · U19 · FY2013 · CA

Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems

$395,717
Manish Aghi · University Of California, San Francisco · R01 · FY2022 · CA

Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis

$395,689
Ann Marie Pendergast · Duke University · R01 · FY2024 · CA

Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer

$395,646
Valeri Vasioukhin · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers

$395,595
Marcus Laird Forrest · Kinimmune, Inc. · R41 · FY2022 · CA

Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy

$395,588
Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA

Sex specific epigenetic regulation of colon cancer metastasis

$395,576
Y. Alan Wang · Indiana University Indianapolis · R01 · FY2023 · CA

Hyaluronan Receptors in Prostate Cancer Progression

$395,561
James B. McCarthy · University Of Minnesota · R01 · FY2008 · CA

Exosomes in HNSCC Progression

$395,533
Alissa M Weaver · Vanderbilt University · R01 · FY2021 · CA

Mechanism regulating ErbB signaling network in head and neck cancer

$395,521
Randall H Kramer · University Of California, San Francisco · R01 · FY2015 · DE

Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors

$395,516
Minah Kim · Columbia University Health Sciences · R37 · FY2024 · CA

Targeting the SKP2 Axis for Anti-melanoma Therapy

$395,509
Hiroyuki Inuzuka · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA

An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers

$395,401
Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA

Localizing Immunotherapy to Improve Therapeutic Index

$395,388
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2016 · CA

Localizing Immunotherapy to Improve Therapeutic Index

$395,388
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2015 · CA

Localizing Immunotherapy to Improve Therapeutic Index

$395,388
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2013 · CA

Localizing Immunotherapy to Improve Therapeutic Index

$395,388
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2017 · CA

Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression

$395,387
Ken S Lau · Vanderbilt University Medical Center · U54 · FY2024 · CA

Project 1: Patterned Heterogeneity in Colon Cancer

$395,367
Marian L Waterman · University Of California-Irvine · U54 · FY2019 · CA

Mechanism and pathways of Glucocorticoid Receptor (GR) signaling in TNBC progression

$395,356
Anna Tate Riegel · Georgetown University · R21 · FY2025 · CA

Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness

$395,280
Wael M. Elshamy · San Diego Biomedical Research Institute · R01 · FY2017 · CA